Cover Image
市場調查報告書

Longevity Biotech, Inc的產品平台分析

Longevity Biotech, Inc - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 326434
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Longevity Biotech, Inc的產品平台分析 Longevity Biotech, Inc - Product Pipeline Review - 2015
出版日期: 2015年02月24日 內容資訊: 英文 29 Pages
簡介

Longevity Biotech, Inc,是致力於新治療用化合物開發的前臨床生物醫藥品企業。

本報告提供Longevity Biotech, Inc的治療藥開發平台的各現狀及各開發階段比較分析、標的、各給藥途徑、各分子類型、各作用機制的治療藥的評估、最近的開發平台趨勢相關資訊等。

Longevity Biotech, Inc的基本資料

Longevity Biotech, Inc概要

  • 主要資訊
  • 企業資料

Longevity Biotech, Inc:R&D概要

  • 主要的治療範圍

Longevity Biotech, Inc:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Longevity Biotech, Inc:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Longevity Biotech, Inc:藥物簡介

  • 代謝性疾病的作用於GLP1和GIP的合成肽
  • HIV的抑制Glycoprotein 41的合成肽
  • 中樞神經系統疾病及糖尿病神經病變的合成肽
  • 癌症用合成肽
  • 代謝性疾病用合成肽
  • 小細胞肺癌的作用於VIP的合成肽
  • 肺動脈高血壓的作用於VPAC2的合成肽
  • 乳癌及大腸癌的作用於VPAC1的合成肽

Longevity Biotech, Inc:開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Longevity Biotech, Inc:暫停中的計劃

Longevity Biotech, Inc:總公司和子公司的所在地

附錄

目錄
Product Code: GMDHC06791CDB

Summary

Global Markets Direct's, 'Longevity Biotech, Inc - Product Pipeline Review - 2015', provides an overview of the Longevity Biotech, Inc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Longevity Biotech, Inc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Longevity Biotech, Inc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Longevity Biotech, Inc's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Longevity Biotech, Inc's pipeline products

Reasons to buy

  • Evaluate Longevity Biotech, Inc's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Longevity Biotech, Inc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Longevity Biotech, Inc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Longevity Biotech, Inc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Longevity Biotech, Inc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Longevity Biotech, Inc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Longevity Biotech, Inc Snapshot
    • Longevity Biotech, Inc Overview
    • Key Information
    • Key Facts
  • Longevity Biotech, Inc - Research and Development Overview
    • Key Therapeutic Areas
  • Longevity Biotech, Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Longevity Biotech, Inc - Pipeline Products Glance
    • Longevity Biotech, Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Longevity Biotech, Inc - Drug Profiles
    • Synthetic Peptide to Agonize GLP1/GIP for Metabolic Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide to Inhibit Glycoprotein 41 for HIV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptides for Central Nervous System Disorders and Diabetic Neuropathy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide 1 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide 2 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Metabolic Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide to Agonize VIP for Small Cell Lung Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide to Agonize VPAC2 for Pulmonary Arterial Hypertension
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide to Antagonize VPAC1 for Breast and Colon Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Longevity Biotech, Inc - Pipeline Analysis
    • Longevity Biotech, Inc - Pipeline Products by Target
    • Longevity Biotech, Inc - Pipeline Products by Route of Administration
    • Longevity Biotech, Inc - Pipeline Products by Molecule Type
    • Longevity Biotech, Inc - Pipeline Products by Mechanism of Action
  • Longevity Biotech, Inc - Dormant Projects
  • Longevity Biotech, Inc - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Longevity Biotech, Inc, Key Information
  • Longevity Biotech, Inc, Key Facts
  • Longevity Biotech, Inc - Pipeline by Indication, 2015
  • Longevity Biotech, Inc - Pipeline by Stage of Development, 2015
  • Longevity Biotech, Inc - Monotherapy Products in Pipeline, 2015
  • Longevity Biotech, Inc - Preclinical, 2015
  • Longevity Biotech, Inc - Discovery, 2015
  • Longevity Biotech, Inc - Pipeline by Target, 2015
  • Longevity Biotech, Inc - Pipeline by Route of Administration, 2015
  • Longevity Biotech, Inc - Pipeline by Molecule Type, 2015
  • Longevity Biotech, Inc - Pipeline Products by Mechanism of Action, 2015
  • Longevity Biotech, Inc - Dormant Developmental Projects,2015

List of Figures

  • Longevity Biotech, Inc - Pipeline by Top 10 Indication, 2015
  • Longevity Biotech, Inc - Pipeline by Stage of Development, 2015
  • Longevity Biotech, Inc - Monotherapy Products in Pipeline, 2015
  • Longevity Biotech, Inc - Pipeline by Top 10 Target, 2015
  • Longevity Biotech, Inc - Pipeline by Top 10 Route of Administration, 2015
  • Longevity Biotech, Inc - Pipeline by Top 10 Molecule Type, 2015
  • Longevity Biotech, Inc - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top